Connection

Lauge Østergaard to Insulin, Long-Acting

Back to Details
This is a "connection" page, showing publications Lauge Østergaard has written about Insulin, Long-Acting.
Lauge Østergaard
Connection Strength
0.680
Insulin, Long-Acting
  1. Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes. Expert Rev Clin Pharmacol. 2017 Jun; 10(6):621-632.
    View in: PubMed
    Score: 0.680
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.